21 C.F.R. § 4.3

What current good manufacturing practice requirements apply to my combination product?

Last amended: 2026Year: 2026Length: 195 wordsSubsections: 5Official source

Cite as 21 C.F.R. § 4.3 (2026)

If you manufacture a combination product, the requirements listed in this section apply as follows: (a) The current good manufacturing practice requirements in parts 210 and 211 of this chapter apply to a combination product that includes a drug constituent part other than a medical gas; (b) The current good manufacturing practice requirements in part 820 of this chapter apply to a combination product that includes a device constituent part; (c) The current good manufacturing practice requirements among the requirements (including standards) for biological products in parts 600 through 680 of this chapter apply to a combination product that includes a biological product constituent part to which those requirements would apply if that constituent part were not part of a combination product; (d) The current good tissue practice requirements including donor eligibility requirements for HCT/Ps in part 1271 of this chapter apply to a combination product that includes an HCT/P; and (e) The current good manufacturing practice requirements in part 213 of this chapter apply to a combination product that includes a drug constituent part that is a medical gas. [78 FR 4321, Jan. 22, 2013, as amended at 89 FR 51766, June 18, 2024]
21 C.F.R. § 4.3: What current good manufacturing practice requirements apply to my combination product? | Justis AI